Delivery Order SPE2DB22D3016-SPE2DB24FBCN7

Award Date 7/30/24
Potential Completion Date 8/20/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the AmerisourceBergen Drug Corporation for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. The contract has a ceiling value of $12,960.30 and an ultimate completion date of September 3, 2024. It is a firm-fixed-price contract, with no set-aside designation. AmerisourceBergen, as the prime contractor, will be responsible for delivering the pharmaceutical product to support the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a prescription medication. The ceiling value of the delivery order is $12,960.30, and it has a firm fixed price pricing type. The period of performance runs from the award date of September 10, 2024, through October 1, 2024. This delivery order is part of a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $12,960.30 firm fixed price contract is for the supply of the prescription drug VYNDAMAX 61 MG CAPSULE UD 30S. The contract has an ultimate completion date of October 8, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999, which enables the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a ceiling value of $12,960.30 and is a firm fixed price contract. The period of performance runs from the award date of July 30, 2024 through the ultimate completion date of August 20, 2024. This contract is not a set-aside. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is...
This is a $26,816.48 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty medication, with a completion date of April 14, 2025. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 IDC with DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of July 12, 2024. This contract is not designated as a set-aside....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $13,408.24, is for the provision of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. The contract has an ultimate completion date of March 24, 2025 and was awarded on March 3, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the purchase of VYNDAMAX 61 MG CAPSULE UD 30S, a pharmaceutical product. The contract has a period of performance through December 9, 2024 and utilizes a firm fixed price pricing type. This award is associated with a larger Indefinite Delivery...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,960.30, is for the delivery of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product, with a completion date of November 20, 2024. The contract type is Firm Fixed Price. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen...
This contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,408.24 firm-fixed-price delivery order is for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a medication, to support federal healthcare programs. The contract has an ultimate completion date of April 3, 2025 and was awarded on March 13, 2025. This delivery order is part of a larger $999,999,999...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FBCN7
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of VYNDAMAX 61 MG CAPSULE UD 30S, a specialty pharmaceutical product. The contract has a ceiling value of $12,960.30 and an ultimate completion date of August 20, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the provision of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract is a firm-fixed-price arrangement, without any set-aside designations.

Generated 10/29/24, 9:19 AM